E-2 Visa Business Plan for a Telehealth Company: What Officers Evaluate

Under 8 CFR 214.2(e)(12) and the guidance at 9 FAM 402.9-4(B)(4), the E-2 investment must be in a real operating enterprise and the funds must be irrevocably committed — at risk of loss — in the active pursuit of the enterprise. For a telehealth company, the qualifying investment pool typically includes: electronic health record (EHR) software licenses or custom platform development costs, credentialing and licensing fees in each state where the company will operate, professional liability and cyber-liability insurance premiums paid in advance, teleconferencing infrastructure and equipment, startup marketing and patient-acquisition costs, lease deposits for any administrative office space, and working capital documented by a capitalized operating account.

Expenses that have already delivered their value before the application — for example, a domain name purchased months ago or a logo design fee — are weaker evidence of at-risk commitment than funds held in escrow or a capitalized business checking account. The stronger presentation places the bulk of investment in accounts or contracts that can still lose value if the business fails: a software development contract where the deliverable is not yet complete, a lease with future rent obligations, or a services agreement that requires continued engagement. Officers reviewing telehealth plans consistently look for a clear bridge between the investor's traced personal funds and the current balance or contracted obligations of the enterprise.

The proportionality test at 9 FAM 402.9-4(B)(5) requires that the investment be substantial relative to the total cost of establishing or acquiring the enterprise. For capital-intensive businesses such as manufacturing or hotels, a lower percentage of the total cost may satisfy substantiality because the absolute dollar amount is large. For low-cost businesses — including many telehealth startups — the percentage requirement is higher, often 75 percent or more of total startup cost when that cost falls below roughly $100,000.

This is where telehealth plans frequently stumble. An officer who sees a business plan projecting $400,000 in first-year revenue and a total capitalization of $30,000 will apply a high proportionality standard and also scrutinize the non-marginality threshold closely. The most effective response is not to inflate the investment artificially, but to document every legitimate cost category meticulously: multi-state licensing fees (which can run $2,000 to $8,000 per state for a clinical practitioner), credentialing fees with insurance networks, platform subscription costs annualized, a realistic marketing budget broken out by channel, and working capital sufficient to sustain three to six months of operations without revenue. If the honest total reaches $75,000 to $150,000 and the investor has fully capitalized that amount, the substantiality argument is solid for a service-based telehealth startup.

Under 8 CFR 214.2(e)(2)(i) and 9 FAM 402.9-4(B)(3), the E-2 investor must enter the United States to develop and direct the enterprise. For a telehealth company, this means the business plan must explain specifically how the investor will manage the clinical, operational, and business-development functions of the company — not simply that the investor will hold ownership. Officers are attentive to plans where a small telehealth platform is owned by an investor who lives outside the United States and the actual clinical and operational work is performed entirely by contracted clinicians and a U.S.-based manager.

The plan should document the investor's qualifications and the active operational role they will perform: managing clinician credentialing, overseeing patient-acquisition strategy, negotiating payer agreements, or directing platform development if the company uses a proprietary software product. If the investor is not a licensed clinician, the plan should explain the organizational structure in which licensed healthcare professionals provide the clinical services while the investor manages the business operations — this is a common and defensible structure, but it must be spelled out explicitly, with the investor's specific day-to-day responsibilities enumerated in the management section.

The non-marginality requirement under 8 CFR 214.2(e)(15) and 9 FAM 402.9-4(B)(6) requires that the enterprise generate income significantly beyond the investor's personal needs or make a significant economic contribution. For telehealth businesses, non-marginality is the most frequently contested element because a solo-practitioner telehealth business — one clinician seeing patients remotely — can be profitable with no employees beyond the owner-investor and may, on its face, appear to exist solely to provide the investor's livelihood.

The business plan must affirmatively address this by projecting the enterprise beyond the investor's personal needs through a credible staffing plan. A typical approach is to show that the company will engage contracted telehealth clinicians (nurse practitioners, physicians, therapists, or other licensed providers) on a per-session or part-time basis within the first year, with a transition to employed clinicians as volume grows. The staffing section should specify job titles, projected hours or visit volumes, projected compensation, and the timeline for each hiring tranche. Officers will evaluate whether the staffing projections are consistent with the revenue projections: if the business plan shows $600,000 in annual revenue but a staffing plan with two part-time contractors, the numbers require explanation, because a volume that large implies significant clinical throughput that cannot be delivered by two part-time contractors.

• Project at least two to three non-investor employees or contractors within 12 to 18 months, with specific titles and compensation
• Tie staffing growth to patient visit volume: document how many visits per week each clinician can handle and what the corresponding revenue per visit is
• If the platform uses an asynchronous model (messaging-based care rather than synchronous video), explain the productivity and staffing implications explicitly
• Include a separate section addressing marginality directly — do not assume the officer will infer non-marginality from the financial tables alone

E-2 business plan financial projections for telehealth enterprises should cover at least three to five years, with monthly detail in year one and annual summaries thereafter. The revenue model must be transparent: officers expect to see patient visit volume assumptions, average revenue per visit (which varies significantly by specialty, payer mix, and whether the practice accepts insurance or operates direct-pay), and the assumed payer mix. A plan that shows $50,000 in monthly revenue in month six without explaining what volume of visits at what price per visit produces that number is not credible.

Cost-side projections must include clinician compensation (which is typically the largest expense line for a telehealth practice), malpractice insurance premiums, platform or EHR subscription fees, billing and collections costs, marketing and patient-acquisition costs, and administrative overhead. The income statement should flow to a break-even analysis showing the number of visits per week at which revenue covers fixed and variable costs, and then to a projection of when the practice reaches that threshold. Cash-flow projections matter separately from the income statement: a telehealth practice accepting insurance will experience a lag between service delivery and reimbursement (typically 30 to 90 days depending on payer), and the cash-flow model must account for that lag, show that the investor's working capital is sufficient to sustain operations through the lag period, and demonstrate solvency through the growth phase.

• Revenue model: visits per week × average revenue per visit × payer mix weighting
• Cost model: clinician compensation, malpractice, EHR/platform fees, billing, marketing, admin
• Break-even analysis: visits per week needed to cover fixed and variable costs
• Cash-flow model: accounts for insurance reimbursement lag (30 to 90 days typical)
• Working capital: sufficient to fund operations through the break-even period without additional infusion

A distinctive feature of telehealth business plans is the regulatory complexity. Clinical telehealth services are subject to state medical practice acts, and many states require providers to hold a license in the state where the patient is located at the time of the visit — not the state where the provider is based. A telehealth company planning to serve patients in multiple states must document its multi-state licensure strategy, which may involve obtaining individual state licenses, participating in interstate compact programs such as the Interstate Medical Licensure Compact (IMLC) for physicians or the APRN Compact for nurse practitioners, or operating through a network model where credentialed clinicians hold the required state licenses independently.

This licensing documentation serves a dual purpose in the E-2 context: it demonstrates that the investor has done serious pre-operational planning (supporting the at-risk and real-enterprise arguments), and it constitutes a legitimate investment cost. Credentialing with commercial insurers and Medicare/Medicaid, if applicable, involves an additional layer of documentation and timeline that the business plan should address, both to set realistic revenue ramp-up expectations and to show that the investor understands the operational requirements of the industry.

First, treating the business plan as a technology pitch. Telehealth entrepreneurs often come from technology or clinical backgrounds and write plans that emphasize the innovative features of their platform or the clinical quality of their services. Officers are not evaluating the quality of the business concept; they are evaluating whether the four E-2 requirements are met. The plan must address investment substantiality, irrevocability, develop-and-direct, and non-marginality specifically — not as an afterthought after ten pages of product description.

Second, underestimating the investment by omitting pre-opening costs. Telehealth companies have significant pre-revenue expenses: clinical credentialing, insurance credentialing, platform configuration, initial marketing campaigns, and the working capital needed to sustain operations through the reimbursement lag. A plan that documents only the first-month lease deposit and a laptop purchase will not support a substantiality argument for most telehealth startups. Third, failing to address the solo-practitioner risk. If the investor is also the primary or only clinical provider, the business plan must explain why the enterprise is not marginal and how it will grow beyond the investor's personal productivity. A plan that projects $180,000 in annual revenue from the investor seeing 20 patients per week at $90 per visit — which is precisely the investor's living wage — will raise a marginality flag regardless of how polished the rest of the document is.